Ticker brief

NBIX NEUROCRINE BIOSCIENCES INC

Consumer, Non-cyclical · Pharmaceuticals

last close
$174.26
1 day
+3.9%
14 days
+10.1%
mkt cap
$17.5B
signals 14d
9
authors 14d
7
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-07-02 · now +0.10 (−1 bearish … +1 bullish)
Who spoke7
authorgradetrader scoresignalsmean sent
@Quantumup1C-1.953+0.03
@TradeIdeasLLCC·1+0.10
@MartyCharginC-0.721+0.25
@spluscollectiveC-2.801+0.55
@RoyLMattoxC-1.341+0.50
@OzmosiHealthC·1+0.25
@CrweWorldC·1+0.20
Recent signals9of 9 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-07-02@Quantumup1+0.10UBS initiates CRNX Buy-$55, citing pullback and pipeline catalysts.
2026-07-01@CrweWorld+0.20Neurocrine initiates a Phase 2 pediatric study of crinecerfont.+3.9%
2026-07-01@OzmosiHealth+0.25Neurocrine initiates Phase 2 study of crinecerfont in pediatric patients.+3.9%
2026-06-28@RoyLMattox+0.50Targeting leading biotech names — Author says these biotech stocks are being targeted.+3.4%
2026-06-28@spluscollective+0.55NBIX described as juicy cup setup with look of 200.+3.4%
2026-06-26@MartyChargin+0.25Says several drug stocks are doing well.+3.4%
2026-06-25@Quantumup1+0.00Raymond James initiated MPLT at Strong Buy with $46 target.+6.1%
2026-06-23@TradeIdeasLLC+0.10Swing setup and price alert watchlist lists multiple tickers.+7.9%
2026-06-22@Quantumup1+0.00Stifel reiterated CRNX Buy and $83 PT after management discussion.+7.8%

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.